VatcheTchekmedyianMD

PubMed

• 1 citations
  Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
  Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schm...> ;Journal of Clinical Oncology. 2024 Mar 20
• 7 citations
  Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
  Joris L Vos, Bharat Burman, Swati Jain, Conall W R Fitzgerald, Eric J Sherman, Lara A Dunn, James V Fetten, Loren S Michel, Anuja Kriplani, Kenneth K Ng, Juliana Eng, ...> ;Nature Medicine. 2023 Dec 1
• 24 citations
  Enhancing Radioiodine Incorporation in-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pi...
  Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S Baxi, Ravinder K Grewal, Steven M Larson, Keith S Pentlow, Sofia Haque, R Michael Tuttle, Mona M Sabra, Stephan...> ;Thyroid. 2022 Mar 1
• 1 citations
  A Case of Cefepime-Induced Immune Thrombocytopenia.
  Rebecca Bystrom, Minkey Wungwattana, Vatche Tchekmedyian> ;Journal of Clinical Pharmacy and Therapeutics. 2021 Nov 2
• 6 citations
  Salivary Gland Cancers.
  Vatche Tchekmedyian> ;Hematology/oncology Clinics of North America. 2021 Oct 1
• 1 citations
  Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.
  Jung Julie Kang, Vatche Tchekmedyian, Nader Mohammed, Alisa Rybkin, S. Kitpanit, Ming Fan, Huili Wang, Stephanie Lobaugh, Zhigang Zhang, Anna Lee, Linda Chen, Yao Yu, ...> ;International Journal of Cancer. 2021 Feb 27
• 38 citations
  SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.
  Mahesh Saqcena, Luis J Leandro-García, Jesper L.V. Maag, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu, Vera Tiedje, Vincent P. Reuter, Jeffrey A....> ;Cancer Discovery. 2021 May 1
• 119 citations
  Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
  Lara Dunn, Eric J. Sherman, Shrujal S. Baxi, Vatche Tchekmedyian, Ravinder K. Grewal, Steven M. Larson, Keith S. Pentlow, Sofia Haque, R. Michael Tuttle, Mona M. Sabra...> ;The Journal of Clinical Endocrinology and Metabolism. 2019 May 1
• 2 citations
  Targeting VEGF and EGFR: a combination worth re-exploring?
  Vatche Tchekmedyian, Eric J. Sherman> ;The Lancet. Oncology. 2018 Aug 1
• 5 citations
  The Effect of Rubric-Guided, Focused, Personalized Coaching Sessions and Video-Recorded Presentations on Teaching Skills Among Fourth-Year Medical Students: A Pilot St...
  Vatche Tchekmedyian, Helen M. Shields, Stephen R. Pelletier, Valeria Pazo> ;Academic Medicine. 2017 Nov 1
• 7 citations
  Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic coma.
  Anne H. O’Donnell-Luria, Alexander P. Lin, Sai Merugumala, Frances Rohr, Susan E. Waisbren, Rebecca M. Lynch, Vatche Tchekmedyian, Aaron D Goldberg, Andrew Bellinger, ...> ;Molecular Genetics and Metabolism. 2017 May 1
• 119 citations
  Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.
  Vatche Tchekmedyian, Eric J. Sherman, Lara Dunn, Crystal Tran, Shrujal S. Baxi, Nora Katabi, Cristina R. Antonescu, Irina Ostrovnaya, Sofia Haque, David G. Pfister, Al...> ;Journal of Clinical Oncology. 2014 May 20
• Join now to see all

Lectures

• A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx. 
  2019 ASCO Annual Meeting - 6/1/2019
• A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC). 
  2019 ASCO Annual Meeting - 6/1/2019
• A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018